CIGNA's Medicare Advantage Filing Status with the Centers for Medicare & Medicaid Services

HARTFORD, Conn.--(BUSINESS WIRE)-- CIGNA (NYSE:CI) announced today that it filed to renew its CIGNA HealthCare of Arizona Medicare Advantage HMO and national Medicare Part D contracts with the Centers for Medicare & Medicaid Services (CMS) for plan year 2011. The company did not file to renew its national Medicare Advantage Private Fee-For-Service (PFFS) contract.

CIGNA Individual PFFS customers along with all individuals joining the plan through the end of 2010 will experience no changes this year. CIGNA will continue to serve its clients, brokers, health care professionals and contractors into 2011 for 2010 claims and other needs.

CIGNA will also continue to offer its comprehensive suite of employer retiree and pre-retiree solutions including group medical plans that supplement Medicare and the CIGNA - Humana Medicare Alliance.

About CIGNA

CIGNA (NYSE:CI), a global health service company, is dedicated to helping people improve their health, well being and sense of security. CIGNA Corporation's operating subsidiaries provide an integrated suite of medical, dental, behavioral health, pharmacy and vision care benefits, as well as group life, accident and disability insurance, to approximately 46 million people throughout the United States and around the world. To learn more about CIGNA, visit www.cigna.com. To sign up for email alerts or an RSS feed of company news, log on to http://newsroom.cigna.com/rss/. Also, follow us on Twitter: @cigna and visit CIGNA’s YouTube channel at http://www.youtube.com/cignatv



CONTACT:

CIGNA
Lindsay Shearer, 603-268-7721
[email protected]

KEYWORDS:   United States  North America  Connecticut

INDUSTRY KEYWORDS:   Health  Professional Services  Insurance  Managed Care

MEDIA:

Logo
 Logo

Suggested Articles

Blues plans have reportedly agreed to a $2.7 billion antitrust settlement.

Premera Blue Cross will pay $6.9 million to HHS over a data breach six years ago that exposed 10 million people's health information.

HHS and the FDA finalized a rule that enables states to seek approval to re-import certain drugs from Canada for a cheaper price.